Abstract:BackgroundNewborn screening (NBS) is an important and successful public health program that helps improve the long-term clinical outcomes of newborns by providing early diagnosis and treatment of certain inborn diseases. The development of next-generation sequencing (NGS) technology provides new opportunities to expand current newborn screening methodologies.MethodsWe designed a a newborn genetic screening (NBGS) panel targeting 135 genes associated with 75 inborn disorders by multiplex PCR combined with NGS. With this panel, a large-scale, multicenter, prospective multidisease analysis was conducted on dried blood spot (DBS) profiles from 21,442 neonates nationwide.ResultsWe presented the positive detection rate and carrier frequency of diseases and related variants in different regions; and 168 (0.78%) positive cases were detected. Glucose-6-Phosphate Dehydrogenase deficiency (G6PDD) and phenylketonuria (PKU) had higher prevalence rates, which were significantly different in different regions. The positive detection of G6PD variants was quite common in south China, whereas PAH variants were most commonly identified in north China. In addition, NBGS identified 3 cases with DUOX2 variants and one with SLC25A13 variants, which were normal in conventional NBS, but were confirmed later as abnormal in repeated biochemical testing after recall. Eighty percent of high-frequency gene carriers and 60% of high-frequency variant carriers had obvious regional differences. On the premise that there was no significant difference in birth weight and gestational age, the biochemical indicators of SLC22A5 c.1400C > G and ACADSB c.1165A > G carriers were significantly different from those of non-carriers.ConclusionsWe demonstrated that NBGS is an effective strategy to identify neonates affected with treatable diseases as a supplement to current NBS methods. Our data also showed that the prevalence of diseases has significant regional characteristics, which provides a theoretical basis for screening diseases in different regions.

Maple syrup urine disease diagnosed in a resource-limited setting in an infant in Nepal: a case report

Neonatal maple syrup urine disease in China: two novel mutations in the BCKDHB gene and literature review

Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease

Eleven Novel Mutations of the BCKDHA, BCKDHB and DBT Genes Associated with Maple Syrup Urine Disease in the Chinese Population: Report on Eight Cases.

Exploring molecular spectrum in thai patients with maple syrup urine disease: unveiling a common variant

Genotypic and Phenotypic Spectrum of maple syrup urine disease in Zhejiang of China

Identification of Eight Novel Mutations in 11 Chinese Patients with Maple Syrup Urine Disease

Permanent Neonatal Diabetes Mellitus in China

An Early Diagnosis Leads to a Good Prognosis: a Patient with Maple Syrup Urine Disease--screened by Tandem Mass Spectrometry.

Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn Screening

A Multicenter Prospective Study of Next-Generation Sequencing-Based Newborn Screening for Monogenic Genetic Diseases in China

Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease

The interplay of psychosis and non‐compliance with fatal outcome in an adult with MSUD

A comprehensive in silico analysis of mutation spectrum of maple syrup urine disease (MSUD) genes in Iranian population

Newborn Screening for Selected Disorders in Nepal: A Pilot Study

Methylmalonic acidemia: A Rare Case Report from Rural India

Maple syrup urine disease diagnosis in Brazilian patients by massive parallel sequencing

Prevalence of Renal and Urinary Tract Diseases among Pediatric Cases Admitted in a Tertiary Hospital in Developing Country

Clinical and Genetic Characteristics and Outcome in Patients with Neonatal Diabetes Mellitus from a Low Middle-income Country

Cryptococcal meningitis in people living with Human Immunodeficiency Virus in Nepal: Perspectives from resource limited setting

Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan